1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Czech Republic Pharmaceuticals and Healthcare Report Q3 2016

Czech Republic Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 74 pages

Includes 3 FREE quarterly updates

BMI View: The Czech Republic will continue to be one of the most attractive markets in the CEE region forpharmaceutical and healthcare investment. A strong economic outlook will be the driving factor behindgrowth and with plans to further increase access to healthcare, pharmaceutical sales are expected toincrease over the coming years.Headline Expenditure Projections

-Pharmaceuticals: CZK78.83bn (USD3.02bn) in 2015 to CZK81.15bn (USD3.28bn) in 2016; +3.0 % inlocal currency terms and +8.7 % in US dollar terms. Forecasts in line with last quarter.

-Healthcare: CZK312.52bn (USD11.97bn) in 2015 to CZK325.75bn (USD13.17bn) in 2016; +4.2% inlocal currency terms and +10.1% in US dollar terms. Forecasts revised upwards from last quarter.

Table Of Contents

Czech Republic Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Czech Republic 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Czech Republic 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Czech Republic 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Czech Republic 2014-2020) 28
Industry Risk Reward Index 29
Central And Eastern Europe Risk/Reward Index - Q3 2016 29
Czech Republic - Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Regulatory Regime 37
Pricing Regime 38
Reimbursement Regime 39
Market Overview 44
Healthcare Sector 45
Table: Healthcare Resources (Czech Republic 2010-2015) 47
Table: Healthcare Personnel (Czech Republic 2010-2015) 47
Table: Healthcare Activity (Czech Republic 2010-2015) 48
Research and Development 51
Clinical Trials 51
Epidemiology 53
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 56
Generic Drugmakers 57
Pharmaceutical Distribution 58
Pharmaceutical Retail Sector 58
Company Profile 59
Zentiva (Sanofi) 59
Demographic Data 63
Demographic Forecast 63
Table: Population Headline Indicators (Czech Republic 1990-2025) 64
Table: Key Population Ratios (Czech Republic 1990-2025) 64
Table: Urban/Rural Population and Life Expectancy (Czech Republic 1990-2025) 65
Table: Population By Age Group (Czech Republic 1990-2025) 65
Table: Population By Age Group % (Czech Republic 1990-2025) 66
Glossary 68
Methodology 70
Pharmaceutical Expenditure Forecast Model 70
Healthcare Expenditure Forecast Model 70
Notes On Methodology 71
Risk/Reward Index Methodology 72
Index Overview 73
Table: Pharmaceutical Risk/Reward Index Indicators 73
Indicator Weightings 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.